Pfizer Inc
Pfizer Reports Strong Third-Quarter 2026 Results And Raises 2026 Guidance
■Focused Execution Drove 32% Operational Revenue Growth of Launched and Acquired Products(1)
Company newsroom
Pfizer Inc
NYSE:PFE
1 releases
Company newsroom
NYSE:PFE
1 releases
■Focused Execution Drove 32% Operational Revenue Growth of Launched and Acquired Products(1)